CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-10 | Holzer Phil M SVP and Controller | Shares withheld for taxes | −248 | $60.13 | $15K | 15,863 |
| 2026-03-10 | Holzer Phil M SVP and Controller | Option exercise | +4,612 | 20,475 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Other disposition | −2,264 | 18,211 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Shares withheld for taxes | −849 | $60.13 | $51K | 17,362 |
| 2026-03-10 | Holzer Phil M SVP and Controller | Option exercise · Market Share Units | −811 | 0 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Option exercise · Market Share Units | −768 | 771 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Option exercise · Performance Shares | −4,612 | 0 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Grant or award · Market Share Units | +5,031 | 5,031 | ||
| 2026-03-10 | Holzer Phil M SVP and Controller | Grant or award · Performance Shares | +7,547 | 7,547 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +838 | 5,549 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −94 | 5,455 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −212 | $60.13 | $13K | 5,243 |
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +1,050 | 6,293 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −113 | 6,180 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −267 | $60.13 | $16K | 5,913 |
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise | +6,304 | 12,217 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Other disposition | −3,095 | 9,122 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Shares withheld for taxes | −912 | $60.13 | $55K | 8,210 |
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Market Share Units | −838 | 0 | ||
| 2026-03-10 | Hoch Lynelle President, Cell Therapy Org. | Option exercise · Market Share Units | −1,050 | 1,052 |
Page 5 of 40 · 799 trades